These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12873044)

  • 1. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer.
    Shoenfeld Y; Nahum A; Korczyn AD; Dano M; Rabinowitz R; Beilin O; Pick CG; Leider-Trejo L; Kalashnikova L; Blank M; Chapman J
    Lupus; 2003; 12(6):436-42. PubMed ID: 12873044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS dysfunction in the antiphospholipid syndrome.
    Katzav A; Chapman J; Shoenfeld Y
    Lupus; 2003; 12(12):903-7. PubMed ID: 14714909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice.
    Katzav A; Ben-Ziv T; Blank M; Pick CG; Shoenfeld Y; Chapman J
    J Neuroimmunol; 2014 Jul; 272(1-2):10-5. PubMed ID: 24837568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome.
    Katzav A; Litvinjuk Y; Pick CG; Blank M; Shoenfeld Y; Sirota P; Chapman J
    Behav Brain Res; 2006 May; 169(2):289-93. PubMed ID: 16530276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies.
    Shrot S; Katzav A; Korczyn AD; Litvinju Y; Hershenson R; Pick CG; Blank M; Zaech J; Shoenfeld Y; Sirota P; Chapman J
    Lupus; 2002; 11(11):736-43. PubMed ID: 12475004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
    Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
    Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome.
    Katzav A; Menachem A; Maggio N; Pollak L; Pick CG; Chapman J
    J Autoimmun; 2014 Dec; 55():86-93. PubMed ID: 25150791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies bind ATP: a putative mechanism for the pathogenesis of neuronal dysfunction.
    Chapman J; Soloveichick L; Shavit S; Shoenfeld Y; Korczyn AD
    Clin Dev Immunol; 2005 Sep; 12(3):175-80. PubMed ID: 16295522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice.
    Pierangeli SS; Barker JH; Stikovac D; Ackerman D; Anderson G; Barquinero J; Acland R; Harris EN
    Thromb Haemost; 1994 May; 71(5):670-4. PubMed ID: 8091396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies.
    Pierangeli SS; Vega-Ostertag ME; Raschi E; Liu X; Romay-Penabad Z; De Micheli V; Galli M; Moia M; Tincani A; Borghi MO; Nguyen-Oghalai T; Meroni PL
    Ann Rheum Dis; 2007 Oct; 66(10):1327-33. PubMed ID: 17261530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.
    Kozora E; Erkan D; Zhang L; Zimmerman R; Ramon G; Ulug AM; Lockshin MD
    Clin Exp Rheumatol; 2014; 32(1):34-40. PubMed ID: 24021640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
    Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
    Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
    Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus erythematosus.
    Coín MA; Vilar-López R; Peralta-Ramírez I; Hidalgo-Ruzzante N; Callejas-Rubio JL; Ortego-Centeno N; Pérez-García M
    Lupus; 2015 Jul; 24(8):875-9. PubMed ID: 25697771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactivity induced by antiphospholipid syndrome serum.
    Menachem A; Chapman J; Katzav A
    Ann N Y Acad Sci; 2009 Sep; 1173():422-6. PubMed ID: 19758181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.